대한핵의학회지 (The Korean Journal of Nuclear Medicine)

대한핵의학회 (The Korean Society of Nuclear Medicine)
권호 표지

경화성 혈관종에서의 높은 FDG 섭취

High FDG Uptake in Sclerosing Hemangioma

  • 이종진 (서울대학교병원 핵의학과) ;
  • 강원준 (서울대학교병원 핵의학과) ;
  • 이동수 (서울대학교병원 핵의학과) ;
  • 정준기 (서울대학교병원 핵의학과) ;
  • 이명철 (서울대학교병원 핵의학과)
  • Lee, Jong-Jin (Departments of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Kang, Won-Jun (Departments of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Lee, Dong-Soo (Departments of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Chung, June-Key (Departments of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Lee, Myung-Chul (Departments of Nuclear Medicine, Seoul National University College of Medicine)
  • 발행 : 2005.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A 42 years old woman underwent F-18 FDG PET because of the incidentally detected lung mass on chest X-ray. PET/CT showed hypermetabolic lesion in the lung right upper lobe and the lung cancer was suspected because of the high FDG uptake. However, pathologic diagnosis was sclerosing hemangioma. There are few reports on the evaluation of sclerosing hemangioma using FDG PET. A report showed a slightly increased uptake (standardized uptake ratio of 1.8) (1), and another report showed unsatisfactory result (2). We suggest that sclerosing hemangioma could be seen as hypermetabolic lesion on the FDG PET.

키워드

참고문헌

  1. Hara M, Iida A, Tohyama J, Miura N, et al: FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 2001;19;215
  2. Tsuduki E, Kawana A, Takeda Y, et al: The usefulness of 11C-Choline-positron emission tomography in the diagnosis of sclerosing hemangioma of the lung: a case report. Nihon Kokyuki Gakkai Zasshi 2002;40;402